AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer's Disease

AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease First Alzheimer’s patient imaged with PI-2620 in ADvance, the... | January 18, 2023

Related Keywords

United States ,Switzerland ,Gary Waanders ,Chris Maggos ,Andrea Pfeifer ,Corey Davis ,Eli Lilly ,Head Of Investor Relations Corporate Communications ,Genentech ,Alliance Medical Group ,International Media ,Life Healthcare Group ,Exchange Commission ,Securities Exchange ,Roche Group ,Association International Conference ,Globenewswire Inc ,Partner Life Molecular Imaging Initiates Phase ,Life Molecular Imaging ,Chief Executive Officer ,International Conference ,Molecular Imaging ,Piramal Imaging ,Medical Group ,Healthcare Group ,Investor Relations ,Securities Act ,Securities Exchange Act ,Financial Review ,Annual Report ,Ac Immune Sa Stock Exchange ,News ,Information ,Press Release ,C ,Immune ,Partner ,Life ,Olecular ,Maging ,Nitiates ,Hase , ,Study ,F ,Au ,Pet ,Iagnostic ,Or ,Disease ,First ,Patient ,Damaged ,Ith ,N Aciu Ch0329023102 ,